candsartan cilexetil

DRUG2 trials

Sponsors

AstraZeneca

Conditions

HypertensionPediatric Hypertension

Phase 3

Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age

CompletedNCT00244634

AstraZenecaPediatric Hypertension

Start: 2003-09-30End: 2005-11-30Target: 238Updated: 2007-12-19

Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age

CompletedNCT00244595

AstraZenecaHypertension

Start: 2003-09-30End: 2006-11-30Target: 235Updated: 2009-12-09